Delivery Order SPE2DB22D3301-SPE2DB25FX9KD

Award Date 1/31/25
Potential Completion Date 2/24/25
Potential Value $8.8K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $8,026.53 firm fixed-price delivery order is for the supply of PROMACTA 50 MG TABLET UU 30S, a pharmaceutical product. The award is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that Amerisourcebergen holds with the DLA Troop Support Medical, which serves as a primary vehicle for...
This federal contract award from the Defense Logistics Agency (DLA) was issued to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $8,835.30 firm-fixed-price delivery order is for the supply of PROMACTA 25 MG TABLET, a specialty medication, to support military healthcare programs. The award is not designated as a set-aside contract. The contract is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $8,026.53 delivery order contract is for the procurement of PROMACTA 50 MG TABLET UU 30S, a pharmaceutical product. The contract is a firm fixed price arrangement with a performance period ending on June 30, 2025. This award is not set aside for any specific business type. Amerisourcebergen Drug Corp holds a...
This federal contract award was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of PROMACTA 12.5 MG TABLET UU 30S. The $11,997.54 firm fixed-price delivery order has an ultimate completion date of October 28, 2024. This award is part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999 that AmerisourceBergen holds with the DLA Troop Support Medical to provide a comprehensive range of medical...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor in the United States. The $3,997.21 firm fixed-price delivery order is for the supply of PROMACTA 25 MG TABLET, a medication used to treat certain blood disorders. This award is a part of a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, for...
This federal contract award is a delivery order valued at $23,983.26 that was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of PROMACTA 25 MG TABLET UU 30S, a pharmaceutical product, with a period of performance through December 6, 2024. The award is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that Amerisourcebergen holds with the...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $26,508.36 Firm Fixed Price delivery order contract is for the supply of PROMACTA 25 MG TABLET medical products. The contract does not have a set-aside designation, indicating open competition. Amerisourcebergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $11,991.63, is for the delivery of PROMACTA 25 MG TABLET UU 30S, a pharmaceutical product. This is a delivery order contract with a firm fixed price pricing type, and the ultimate completion date is November 15, 2024. The contract is not designated as a set-aside, indicating open competition....
This federal contract award, with ID SPE2DB25D3202|SPE2DB25FTAGT, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $4,418.06 firm fixed-price delivery order is for the supply of 4568121296 PROMACTA 25 MG TABLET UU 30S, with a completion date of May 23, 2025. The contract is not set aside and is part of Amerisourcebergen's larger $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA...
This federal contract award, with ID SPE2DB22D1017|SPE2DB25FG0JC, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $8,026.53, is a Firm Fixed Price Delivery Order for the supply of PROMACTA 50 MG TABLET UU 30S, a pharmaceutical product. The contract has an ultimate completion date of May 7, 2025 and was awarded on April 16, 2025. It is not designated as a set-aside...
  • SPE2DB22D3301
    Indefinite Delivery Contract
  • SPE2DB22D3301-SPE2DB25FX9KD
    Delivery Order

This federal contract award, with the ID SPE2DB22D3301|SPE2DB25FX9KD, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $8,836.12 firm-fixed-price delivery order is for the supply of PROMACTA 25 MG TABLET UU 30S, a pharmaceutical product. This award is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract has no set-aside designation, indicating open competition. This contract supports the DLA's mission of providing medical commodities, including specialty medications, brand-name and generic drugs, vaccines, syringes, vials, and test kits, to military treatment facilities, veterans' healthcare programs, and other federal medical institutions.

Generated 5/2/25, 9:54 AM